Chittorgarh.com Logo
FREE Account Opening + No Clearing Fees + Rs 999 API
Loading...

Makers Laboratories Rights Issue 2022 Latest News Today

Makers Laboratories Rights Issue 2022 Detail
Issue Open Apr 18, 2022
Issue Close Apr 27, 2022
Issue Size (Shares) 0.10 Crores
Issue Size (Amount) ₹14.75 Crores
Issue Price ₹150 per Share
Listing At BSE
  1. MAKERS LABORATORIES LTD. - Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Rights Equity Shares

    May 6, 2022 8:58:00 AM

    This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has allotted 9,83,396 equity shares of Rs. 10/- each @ Rs. 150/- per share, including a premium ...

    Publish by : money.rediff
  2. Corporate Radar: Rights issues, AGMs, stock splits & more

    May 6, 2022 6:28:00 AM

    Two stocks Crisil and Vedanta will go ex-dividend today. Vedanta had announced an interim dividend of Rs 31.50 per share while the Crisil board had announced Rs 7 per share in dividend.

    Publish by : India Times
  3. Abbott says agreement reached to reopen baby formula plant

    May 17, 2022 12:31:00 AM

    Infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage tied to the ...

    Publish by : CTV News
  4. Baby formula maker Abbott says it has reached deal to restart production

    May 17, 2022 12:49:00 AM

    WASHINGTON (AP) ó Infant formula maker Abbott says itís reached an ... Michigan plantís shutdown earlier this year over safety issues. A consent decree between the producer, Abbott, and ...

    Publish by : WTTV

Read Makers Laboratories Rights Issue 2022 current news. Find Makers Laboratories Rights Issue 2022 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Makers Laboratories Limited Rights Issue grey market premium and Makers Laboratories Rights Issue 2022 expected listing price.


Comments

Add a public comment...